These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9918131)

  • 1. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response.
    Arranz MJ; Li T; Munro J; Liu X; Murray R; Collier DA; Kerwin RW
    Pharmacogenetics; 1998 Dec; 8(6):481-4. PubMed ID: 9918131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects.
    Kohn Y; Ebstein RP; Heresco-Levy U; Shapira B; Nemanov L; Gritsenko I; Avnon M; Lerer B
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):39-43. PubMed ID: 9088883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients.
    Scharfetter J; Chaudhry HR; Hornik K; Fuchs K; Sieghart W; Kasper S; Aschauer HN
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):17-20. PubMed ID: 10647091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Ishida M; Furukori H; Kaneko S; Inoue Y; Otani K
    Pharmacogenetics; 2001 Aug; 11(6):545-50. PubMed ID: 11505224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.
    Xiao L; Shen T; Peng DH; Shu C; Jiang KD; Wang GH
    J Int Med Res; 2013 Aug; 41(4):1171-8. PubMed ID: 23816932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.
    Huang E; Maciukiewicz M; Zai CC; Tiwari AK; Li J; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Kennedy JL
    Pharmacogenomics; 2016; 17(2):103-9. PubMed ID: 26666695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.
    Ohara K; Nagai M; Tani K; Nakamura Y; Ino A; Ohara K
    Psychiatry Res; 1998 Nov; 81(2):117-23. PubMed ID: 9858029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.
    Hwang R; Shinkai T; De Luca V; Müller DJ; Ni X; Macciardi F; Potkin S; Lieberman JA; Meltzer HY; Kennedy JL
    Psychopharmacology (Berl); 2005 Aug; 181(1):179-87. PubMed ID: 15830237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. -141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
    Zhao X; Huang Y; Chen K; Li D; Han C; Kan Q
    Asia Pac Psychiatry; 2016 Sep; 8(3):189-98. PubMed ID: 26346037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes.
    Zhang XR; Zhang ZJ; Zhu RX; Yuan YG; Jenkins TA; Reynolds GP
    Pharmacogenomics; 2011 Aug; 12(8):1127-36. PubMed ID: 21749219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.
    Arranz MJ; Munro J; Owen MJ; Spurlock G; Sham PC; Zhao J; Kirov G; Collier DA; Kerwin RW
    Mol Psychiatry; 1998 Jan; 3(1):61-6. PubMed ID: 9491814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
    Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
    Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
    Mihara K; Kondo T; Suzuki A; Yasui N; Ono S; Otani K; Kaneko S
    Psychiatry Res; 2001 Feb; 101(1):33-8. PubMed ID: 11223117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients.
    Lencz T; Robinson DG; Xu K; Ekholm J; Sevy S; Gunduz-Bruce H; Woerner MG; Kane JM; Goldman D; Malhotra AK
    Am J Psychiatry; 2006 Mar; 163(3):529-31. PubMed ID: 16513877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
    Rietschel M; Naber D; Oberländer H; Holzbach R; Fimmers R; Eggermann K; Möller HJ; Propping P; Nöthen MM
    Neuropsychopharmacology; 1996 Nov; 15(5):491-6. PubMed ID: 8914122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia.
    Shaikh S; Collier DA; Sham PC; Ball D; Aitchison K; Vallada H; Smith I; Gill M; Kerwin RW
    Hum Genet; 1996 Jun; 97(6):714-9. PubMed ID: 8641685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.
    Scharfetter J
    Pharmacogenomics; 2004 Sep; 5(6):691-8. PubMed ID: 15335289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia.
    Tallerico T; Ulpian C; Liu IS
    Psychiatry Res; 1999 Feb; 85(2):215-9. PubMed ID: 10220012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.
    Jönsson EG; Nöthen MM; Neidt H; Forslund K; Rylander G; Mattila-Evenden M; Asberg M; Propping P; Sedvall GC
    Schizophr Res; 1999 Nov; 40(1):31-6. PubMed ID: 10541004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.